Chronix Biomedical's Unattributed VC - IV Round

Chronix Biomedical raised a round of funding on May 18, 2017. Investors include PrairieGold Venture Partners.

Chronix Biomedical is a US-based molecular diagnostics company developing blood tests primarily for the screening and monitoring of cancer. Chronix offers supplemental screening evaluation tests based…

Articles about Chronix Biomedical's Unattributed VC - IV Round: